Team
Three founders, one platform
The science and the business have been in the same room since the beginning. Two of the three founders invented the methods; the third has commercialised diagnostics for twenty-five years.
Jim Hauert
Twenty-five years in global healthcare commercialisation, with executive roles at ADMA Biologics and Baxter Bioscience before founding Gila Diagnostics. Responsible for taking MISPA™ from a research platform to a commercial one.
LinkedIn ↗
Joshua LaBaer, MD, PhD
Founder and former director of the Harvard Institute of Proteomics, and the first Piper Chair in Personalized Medicine at the Biodesign Institute, Arizona State University. He has spent his career building the protein-array methods MISPA™ is descended from, and is corresponding author on both publications.
LinkedIn ↗
Ji Qiu, PhD
Biodesign Institute, Arizona State University. Co-author on both publications and co-inventor of the methods behind the platform.
Latest press
One vaccine, many different responses
Joshua LaBaer on Arizona Horizon, on the study behind the September 2026 paper and what an antibody profile reveals that a single measurement cannot.
Collaborate
Start with a question.
End with insight.
Two things start a collaboration. Everything else follows from them.